Regular review: Drug treatment of multiple sclerosis
- 19 August 2000
- Vol. 321 (7259) , 490-494
- https://doi.org/10.1136/bmj.321.7259.490
Abstract
Methods We have concentrated mainly on drugs that have been specifically approved for use in multiple sclerosis. Our sources included papers from Medline, information from international meetings on multiple sclerosis, and ongoing discussions with colleagues.Keywords
This publication has 25 references indexed in Scilit:
- A quantitative analysis of oligodendrocytes in multiple sclerosis lesionsBrain, 1999
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosisAnnals of Neurology, 1998
- New insights into the immunogenetics of multiple sclerosisCurrent Opinion in Neurology, 1997
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in PathogenesisBrain Pathology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisAnnals of Neurology, 1995
- Overview of azathioprine treatment in multiple sclerosisThe Lancet, 1991